Clinical trial
A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
NCT00076323 · Walter Reed Army Institute of Research (WRAIR), U.S. Fed · Completed
Key facts
| NCT number | NCT00076323 |
|---|---|
| Title | A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency |
| Official title | A New Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency |
| Lead sponsor | Walter Reed Army Institute of Research (WRAIR), U.S. Fed |
| Status | Completed |
| Study type | Interventional |
| Conditions | Glucosephosphate Dehydrogenase Deficiency, Favism |
| Intervention type | Drug |
| Interventions | Primaquine |
| Enrollment | 14 |
| Start date | Dec 1, 2003 |
| Completion | Nov 1, 2006 |
| First posted | Jan 21, 2004 |
| Last update posted | Jul 27, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: